LATE STAGE ADJUVANT MIMICS BASED ON TLR4 AGONISTS
PAI LIFE SCIENCES INC · Department of Health and Human Services
Phase I2022$597,953
The proprietary combination adjuvants AS01 and AS04 are used in approved vaccines (Shingrix and Cervarix, respectively). Another successful adjuvant, GLA-SE, is currently in late-stage clinical trials. To make these cla…